Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 21Active not recruiting 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Thoracic 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Breast Neoplasms 17Neoplasms 14Neoplasm Metastasis 10Ovarian Neoplasms 9Multiple Myeloma 7Melanoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Colorectal Neoplasms 7Carcinoma, Renal Cell 7Urinary Bladder Neoplasms 6Small Cell Lung Carcinoma 6Lymphoma, Non-Hodgkin 6Thyroid Neoplasms 5Thyroid Cancer, Papillary 5Recurrence 5Prostatic Neoplasms 5Pancreatic Neoplasms 5Lung Neoplasms 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Lymphoma 4Urothelial Cancer 3Stomach Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Neurofibromatosis 1 3

Interventions

pembrolizumab 4Saline Solution 1Paclitaxel 1Glucose 1Docetaxel 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Has announcements × Parkinson Disease 4, Autosomal Dominant Lewy Body × Clear all
NCT03765918 2026-05-12

MK-3475-689

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
714 enrolled 90 charts 1 FDA
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Head and Neck Neoplasms

NCT05116189 2026-03-09

KEYNOTE-B96

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
643 enrolled 17 charts 1 FDA
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02628067 2025-09-22

KEYNOTE 158

Merck Sharp & Dohme LLC

Phase 2 Active not recruiting
1,609 enrolled 4 FDA
EndocrineGastrointestinalGynecologicHead & NeckNETOther solid neoplasmThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Anus Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Uterine Cervical Neoplasms, Mesothelioma, Parotid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Microsatellite Instability, Small Cell Lung Carcinoma

NCT03553836 2024-11-29

KEYNOTE-716

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
976 enrolled 15 charts 1 FDA
Dermatologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡